Kestra Medical Technologies, Ltd. (KMTS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kestra Medical Technologies, Ltd., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -10.47x | -11.49x | -12.84x | -31.72x | -36.71x |
| P/B Ratio | 5.80x | -5.17x | -9.20x | 612.58x | 280.48x |
| P/S Ratio | 19.92x | 38.89x | 141.78x | 0.00x | 0.00x |
| Profitability | |||||
| Gross Margin | 40.5% | 1.3% | -139.6% | 0.0% | 0.0% |
| Operating Margin | -177.8% | -305.8% | -1054.0% | 0.0% | 0.0% |
| Net Margin | -190.3% | -338.4% | -1104.0% | 0.0% | 0.0% |
| EBITDA Margin | -163.8% | -274.3% | -966.4% | 0.0% | 0.0% |
| Liquidity | |||||
| Current Ratio | 6.72x | 0.45x | 0.50x | 3.96x | 1.54x |
| Quick Ratio | 6.55x | 0.35x | 0.44x | 3.96x | 1.54x |
| Leverage | |||||
| Debt/Equity | 0.22x | -0.22x | -0.33x | 12.94x | 0.12x |
YoY = year-over-year change. Source: FMP..